Cleared Traditional

K172335 - Bleep DreamPort

K172335 is an FDA 510(k) clearance for Bleep DreamPort, manufactured by Snapcpap. The device is a Class 2 Anesthesiology device with product code BZD cleared through the Traditional 510(k) pathway after a 240-day FDA review.

K172335 · Snapcpap · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2018
Decision
240d
Days
Class 2
Risk

K172335 is an FDA 510(k) clearance for the Bleep DreamPort. Classified as Ventilator, Non-continuous (respirator) (product code BZD), Class II - Special Controls.

Submitted by Snapcpap (Pittsboro, US). The FDA issued a Cleared decision on March 30, 2018 after a review of 240 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5905 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Snapcpap devices

FDA 510(k) Submission Details - K172335

510(k) Number K172335 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 02, 2017
Decision Date March 30, 2018
Days to Decision 240 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
100d slower than avg
Panel avg: 140d · This submission: 240d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BZD Device Classification - Class 2, Special Controls

Product Code BZD Ventilator, Non-continuous (respirator)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5905
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

Snapcpap C/O Promedic, LLC
Paul Dryden

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - BZD Ventilator, Non-continuous (respirator)

All 306
Devices cleared under the same product code (BZD) and FDA review panel - the closest regulatory comparables to K172335.
Transcend 365 miniCPAP System
K180388 · Somnetics International, Inc. · Nov 2018
F&P SleepStyle
K173193 · Fisher &Paykel Healthcare , Ltd. · Aug 2018
Scone Mask
K180497 · Resmed, Ltd. · Jun 2018
AirFit F20
K170924 · Resmed, Ltd. · Jan 2018
AirFit N20
K171212 · Resmed, Ltd. · Sep 2017
F&P InfoSmart
K161686 · Fisher &Paykel Healthcare , Ltd. · Jan 2017